VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,787,000 | -28.5% | 65,269 | +0.1% | 0.18% | -17.8% |
| Q1 2022 | $2,501,000 | +33.2% | 65,208 | +11.3% | 0.22% | +57.6% |
| Q4 2021 | $1,877,000 | -0.4% | 58,611 | -8.3% | 0.14% | -10.3% |
| Q3 2021 | $1,884,000 | -52.3% | 63,916 | -45.0% | 0.16% | -52.3% |
| Q2 2021 | $3,949,000 | +86.0% | 116,230 | +78.0% | 0.32% | +65.8% |
| Q1 2021 | $2,123,000 | -21.7% | 65,315 | -13.3% | 0.20% | -16.2% |
| Q4 2020 | $2,713,000 | +2.5% | 75,332 | +11.4% | 0.23% | -18.8% |
| Q3 2020 | $2,648,000 | -37.3% | 67,614 | -41.2% | 0.29% | -41.9% |
| Q2 2020 | $4,221,000 | +31.4% | 115,064 | -19.1% | 0.50% | +16.7% |
| Q1 2020 | $3,213,000 | -68.8% | 142,175 | -59.5% | 0.42% | -56.3% |
| Q4 2019 | $10,288,000 | +10.9% | 351,377 | +1.2% | 0.97% | +1.7% |
| Q3 2019 | $9,275,000 | +312.0% | 347,265 | +294.4% | 0.96% | +214.8% |
| Q2 2019 | $2,251,000 | – | 88,052 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |